This is the third update since its board of directors announced on April 6 that it had “received indication of interest from persons who are considering acquisition of a stake in the company”.
Medical oncology and stem cell services provider TalkMed Group, which announced in April “interest” from “persons” considering the acquisition of a stake in the company, says the discussions remain “preliminary”.
“There is no assurance that a transaction will take place,” reads a July 22 bourse filing.
